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The objective of this survey was to determine the distribution ofClostridium difficile PCR ribotypes
present across three Hungarian geographical regions. A total of 105 isolates of C. difficile
from diarrhoeal faeces of both inpatients and outpatients were examined. The toxigenic status of the
strains was determined by PCR for the tcdA, tcdB, cdtA and cdtB genes in Szeged (Hungary),
while strains were subjected to PCR ribotyping in Cardiff (UK). A total of 31 ribotypes were
detected among the 105 C. difficile isolates tested. Five PCR ribotypes were distinct from all
previously described types, suggesting that they are new. The most common types in Hungary,
during the period examined, were PCR ribotype 014 (24?8%) and PCR ribotype 002 (13?3%). The
distribution of PCR ribotypes differed in the various Hungarian regions: PCR ribotype 012 was
frequent (20?7%) in South Hungary, whereas this type was rare in the Budapest region andwas not
common to West Hungary. In West Hungary and the Budapest region, PCR ribotype 014 was
most frequent (28?9 and 29%, respectively).
INTRODUCTION
Numerous surveys have revealed that the most frequent
nosocomial enteritic pathogen is toxin-producingClostridium
difficile (Barbut et al., 1995; McFarland, 1995; Spencer, 1998).
The wide application and, in many cases, the misuse of differ-
ent antibiotics has led to an increasing number of cases of
C. difficile-associated disease, primarily in the hospital envir-
onment (Bartlett, 1992; Brown et al., 1990; Spencer, 1998). At
the same time, community-acquired infections are probably
underdiagnosed, and few reports deal with this problem
(Barbut et al., 2005; Noren et al., 2004; Riley et al., 1995).
Because of the emergence of new toxin variant strains, and the
spread of toxin A-positive and toxin B-positive strains in
hospitals and the community, further investigations of these
strains may be important for elucidating the exact role of
toxin variant strains in the pathogenesis of disease and for
controlling the spread of these bacteria.
Numerous molecular typing methods, such as arbitrarily
primed-PCR, RFLP, PFGE and PCR ribotyping, have been
used internationally to study C. difficile strains of different
origins (Brazier, 2001). Most of these typing methods are
suitable for following outbreaks, determining recurrences,
characterizing endemic strains and tracing the spread of C.
difficile. PCR ribotyping is a method that is widely used
(Rotimi et al., 2003; Stubbs et al., 1999; Urba´n et al., 2001)
to determine the intraspecies genetic variation of C. difficile,
and in which the 16S and 23S rRNA intergenic spacer region
can be amplified by using specific primers under stringent
amplification conditions. The sizes of the amplification pro-
ducts can range from 250 to 600 bp (Brazier, 2001).
In an earlier study in Hungary in collaboration with the
Anaerobe Reference Laboratory (Cardiff), 65 C. difficile iso-
lates were typed using PCR ribotyping (Urba´n et al., 2001).
The aim of the present study was to extend this investigation
and to determine the distribution of PCR ribotypes in three
Hungarian regions.
METHODS
C. difficile strains and detection of toxin genes. A total of 105
C. difficile isolates from diarrhoeal faeces at Hungarian laboratories
in the towns of Szeged, Szolnok (South Hungary), Budapest
(Budapest region) and Veszpre´m (West Hungary), collected between
2002 and 2004, were included in the study. Of the 105 isolates, 65
were obtained from inpatients, and 40 from outpatients. A total of
99 isolates were selected from our previous study (Terhes et al.,
2004), in which the main toxin genes and binary toxin genes were
analysed, and 6 other toxigenic strains were chosen from our strain
collection. The toxin A and B genes (tcdA and tcdB, respectively),
and the binary toxin genes (cdtA and cdtB), were detected by PCR.
PCR was also used to determine the deletion at the 39 end of
the tcdA gene (Kato et al., 1991, 1998; Stubbs et al., 2000). These
analyses were performed at the Hungarian Anaerobe Reference
Laboratory, Szeged. In these cases, the tcdA/tcdB-positive control
strain was the reference strain VPI 10463 (toxinotype 0), which was
obtained from the American Type Culture Collection (Rockville,
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Maryland, USA), while the binary toxin-producing control strains
R5989 (ribotype 023), R8637 (ribotype 019) and R10456 (ribotype
058) were part of the collection of the Anaerobe Reference Labo-
ratory, Cardiff, UK.
Culturing conditions and extraction of DNA. For PCR ribotyp-
ing, strains were grown on Fastidious Anaerobe Agar (LabM); the
plates were incubated at 37 uC for 24 h under anaerobic conditions.
After checking the colony morphology, fluorescence under UV light
and the purity of the cultures, the cells were resuspended in a 5 %
(w/v) solution of Chelex-100 (Bio-Rad). The solutions were incu-
bated in boiling water for 12 min and then centrifuged at 15 000 g
for 10 min. The supernatant was removed, placed in a fresh tube
and stored at 4 uC for 12–24 h.
PCR ribotyping. Amplification reactions were performed in a 100 ml
volume containing 50 pmol each primer (16S rRNA gene primer p3
59-CTG GGG TGA AGT CGT AAC AAG G-39, position 1445–1466,
and 23S rRNA gene primer p5 59-GCG CCC TTT GTA GCT TGA
CC-39, position 1–20), 200 mM dNTP (Pharmacia), 10 mM Tris/
HCl (pH 8?8), 50 mM KCl, 1?5 mM MgCl2, 1 U Taq polymerase
(Pharmacia), and 10 ml template DNA. PCR was carried out in a
thermal cycler, for 1 cycle of 120 s at 95 uC, for starting denatura-
tion, and 30 cycles of denaturation at 92 uC for 60 s, annealing at
55 uC for 60 s and extension at 72 uC for 90 s. After the last dena-
turation step, annealing was carried out at 55 uC for 45 s, and exten-
sion at 72 uC for 5 min (Stubbs et al., 1999).
Detection of the PCR products. Amplification products were
concentrated to a final volume of 25–30 ml in a heat-block set at
75 uC for 1?5 h. PCR products were detected by electrophoresis in
3 % (w/v) metaphor agarose gels (BMA-BioWhittaker Molecular
Applications) for 3 h, at 200 V and 60 mA in TAE buffer [40 mM
Tris-acetate, 1 mM EDTA (pH 8?0)]. The DNA banding pattern was
visualized under UV light after staining for 20 min in ethidium bro-
mide (0?5 mg ml21). A molecular mass ladder (Superladder-Low;
ABgene) was included every six wells on the gels for normaliza-
tion of the gel patterns. PCR ribotype profiles were analysed with
GelCompar image analysis software (version 4.0; Applied Maths).
RESULTS AND DISCUSSION
Of the 105 C. difficile isolates originating from diarrhoeal
faeces examined, 83 carried tcdA and tcdB genes, while 22
were tcdA/B-negative. These 22 non-toxigenic strains were
isolated from adults aged between 29 and 79 years, except
for 5 isolates that originated from children aged less than
3 years. In these cases, diarrhoeal faeces were tested for
the presence of other common enteritic pathogens, such
as enteropathogenic Escherichia coli, Salmonella, Shigella,
Yersinia, Campylobacter, adenoviruses and rotaviruses. All
of these screening tests were negative. No toxin A-negative
and toxin B-positive isolates were recovered. A total of 23
different ribotypes were detected, and a comparison with
the patterns recorded in the C. difficile library of PCR ribo-
types in the Cardiff type culture collection revealed 5 new
ribotypes, termed PCR ribotypes 161, 162, 164, 165 and 166
(Fig. 1). During the period examined, the most prevalent
types among the Hungarian isolates overall were PCR
ribotypes 014 (24?8 %), 002 (13?3 %) and 085 (8?6 %).
Most of the toxin-negative strains belonged to PCR ribo-
type 085 (9/22 isolates). The distribution of the ribotypes
differed in the three geographical regions: in the Budapest
region the dominant types were ribotypes 014, 002 and 018
(29, 19?4 and 12?9 %, respectively), whereas 014 (28?9 %),
049 (11?1 %), 085 (8?9 %) and 002 (8?9 %) were most
frequent in West Hungary, and ribotypes 012 (20?7 %), 002
(13?8 %) and 014 (13?8 %) were characteristic of South
Hungary. Type 049 (11?1 %) was present only in West
Hungary, while ribotype 005 (9?7 %) was detected only in
the Budapest region, and ribotype 035 (6?9 %) was observed
only in South Hungary (Table 1). The presence of binary
toxin-producing strains was demonstrated in West Hungary
and the Budapest region, but not in South Hungary. The
frequencies of the various ribotypes were compared between
inpatients and outpatients. When the two-sided Fisher’s
exact test was used, the differences were not significant
except in one case (ribotype 012), which was more prevalent
among isolates obtained from inpatients.
In 2001, 65 C. difficile isolates from the University Hospital
of Szeged were typed in cooperation with the Anaerobe
Reference Laboratory (Cardiff) by PCR ribotyping. In that
survey, 57 strains were isolated from diarrhoeal faeces and
8 from different clinical specimens, e. g. wound, bile and
intra-abdominal samples. The strains examined belonged
to 15 different ribotypes; the most frequent type, ribotype
087, accounted for 39 % of all the strains (Urba´n et al.,
2001). During the present study this ribotype was found less
frequently (one isolate in South Hungary and one in West
Hungary). The results from the local university hospital in
2001 and the results of the present survey indicate changes in
the prevalence and distribution of the various C. difficile
ribotypes.
These data suggest that the distribution of C. difficile may
change over time and geographically. We have shown that
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Fig. 1. A representative example of PCR ribotyping patterns of
C. difficile. M, molecular size marker (Superladder-Low;
ABgene). Ribotypes 012 and 014 were characteristic ribotypes
during the isolation period, ribotype 161 is a new type, ribo-
types 010 and 085 are toxin-negative isolates, ribotype 001 is
a toxin-positive isolate and ribotype 159 is a control from the
Cardiff strain collection.
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there can be regional differences within a country. A number
of ribotyping surveys in various countries have also demon-
strated different distributions of ribotypes. For example,
type 001 was detected in the majority of UK hospital infec-
tions (55 %), while only comprising 7?5 % of strains caus-
ing community-acquired infections in England and Wales
(Stubbs et al., 1999). In Kuwait, PCR ribotypes 097 and 078
accounted for ~40 % of all isolates in intensive-therapy
units (Rotimi et al., 2003).
In 2001, binary toxin-producing isolates were not observed
among strains originating from Szeged University Hospital,
whereas binary toxin genes were detected in three isolates
between 2002 and 2004. The presence of toxin was also pro-
ven using Western blotting. Two of the three binary toxin-
positive strains were isolated and identified from severe
community-acquired diarrhoea after antibiotic therapy in
West Hungary and the Budapest region (Terhes et al., 2004),
and PaLoc analysis showed that the strains belonged to
toxinotypes III and IV, which produce toxins A and B. These
isolates caused severe diarrhoea, but the exact role of the
binary toxin in pathogenesis has not yet been clarified. Some
clinical studies suggest that the binary toxin can be an
additional virulence factor that may enhance the severity of
infection (Barbut et al., 2005).
During the past 10 years, numerous molecular typing
methods have been developed to differentiate nosocomial
C. difficile strains. Some of these methods can provide useful
information, especially during hospital outbreaks. In each
case, the most important expectations are that the methods
should be discriminative, reproducible, simple and rapid.
PFGE is accepted as the gold-standard technique for the
typing of bacterial strains, but the majority of C. difficile
isolates cannot be typed because of the degradation of
the DNA. Moreover, this method is rather labour-intensive
and time-consuming (Hyett et al., 1997; Kato et al., 1996).
PCR ribotyping is one of the most frequently used methods
for the epidemiological investigation of C. difficile. The
present study compared the ribotypes of C. difficile strains
from three parts of Hungary with the results of earlier
international and national ribotyping studies. Both regional
and international differences were observed in relation to
the distribution of various ribotypes, and changes in the
prevalence of the different ribotypes over time were also
apparent. Because of the increasing numbers of hospital
infections and outbreaks caused by C. difficile the intro-
duction of typing methods in more countries is essential
for establishing a database relating to the spread of the
most frequent epidemic C. difficile strains. Such a database
would be of great help in the future demonstration of
Table 1. Distribution of PCR ribotypes in three Hungarian regions
Ribotype Toxin A/B Binary toxin Budapest region West Hungary South Hungary Total
001 +/+ 2 2 1 0 3
002 +/+ 2 6 4 4 14
005 +/+ 2 3 0 0 3
009 2/2 2 0 1 1 2
010 2/2 2 0 3 2 5
011 +/+ 2 0 2 0 2
012 +/+ 2 1 0 6 7
013 +/+ 2 0 1 0 1
014 +/+ 2 9 13 4 26
018 +/+ 2 4 1 0 5
020 +/+ 2 0 0 1 1
023 +/+ + 1 1 0 2
035 2/2 2 0 0 2 2
039 2/2 2 0 1 0 1
046 +/+ 2 0 1 0 1
049 +/+ 2 0 5 0 5
072 +/+ 2 0 1 0 1
075 +/+ + 1 0 0 1
078 +/+ 2 0 0 1 1
085 2/2 2 2 4 3 9
087 +/+ 2 0 1 1 2
128 2/2 2 0 1 0 1
150 +/+ 2 1 1 1 3
161 +/+ 2 1 0 2 3
162 +/+ 2 0 1 0 1
164 2/2 2 0 1 0 1
165 +/+ 2 0 1 0 1
166 2/2 2 0 0 1 1
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outbreaks, and in the distinction between recurrences and
reinfections.
ACKNOWLEDGEMENTS
This work was supported by a Hungarian Eotvos Scholarship
(Gabriella Terhes, 2003/2004).
We are grateful to Frederic Barbut, Department of Microbiology and
Infectious Control Unit, Hoˆpital Saint-Antoine, Assistance Publique-
Hoˆpitaux de Paris, Paris, France for performing the binary toxin
Western blotting and toxinotyping of binary toxin-producing isolates.
We are grateful to Galina Riszkulova, Ma´ria To¨mo¨ry, Anna Tusna´di,
Ma´ria Vollain and Kanjo Abdul Hamid for kindly providing C. difficile
isolates.
This paper was presented in part as a poster (no. 1146) at the 15th
European Congress of Clinical Microbiology and Infectious Diseases in
Copenhagen, Denmark, on 2–5 April 2005.
REFERENCES
Barbut, F., Leluan, P., Antoniotti, G., Collignon, A., Sedallian, A. &
Petit, J. C. (1995). Value of routine stool cultures in hospitalized
patients with diarrhea. Eur J Clin Microbiol Infect Dis 14, 346–349.
Barbut, F., Decre, D., Lalande, V. & 9 other authors (2005). Clinical
features of Clostridium difficile-associated diarrhoea due to binary
toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med
Microbiol 54 (Suppl.), 181–185.
Bartlett, J. G. (1992). Antibiotic-associated diarrhea. Clin Infect Dis
15, 573–581.
Brazier, J. S. (2001). Typing of Clostridium difficile. Clin Microbiol
Infect 7, 428–431.
Brown, E., Talbot, G. H., Axelrod, P., Provencher, M. & Hoegg, C.
(1990). Risk factors for Clostridium difficile toxin-associated diarrhea.
Infect Control Hosp Epidemiol 11, 283–290.
Hyett, A. P., Brazier, J. S. & O’Neil, G. L. (1997). Pulsed-field gel
electrophoresis as a method for typing Clostridium difficile in the
routine laboratory. Rev Med Microbiol 8 (Suppl.), 63–64.
Kato, N., Ou, C. Y., Kato, H., Bartley, S., Brown, V. K., Dowell, V. R. &
Ueno, K. (1991). Identification of toxigenic Clostridium difficile by
the polymerase chain reaction. J Clin Microbiol 29, 33–37.
Kato, H., Kato, N., Watanabe, K., Ueno, K., Sakata, Y. & Fujita, K.
(1996). Relapses or reinfections: analysis of a case of Clostridium
difficile-associated colitis by two typing systems. Curr Opin Microbiol
33, 220–223.
Kato, H., Kato, N., Watanabe, K. & 7 other authors (1998). Iden-
tification of toxin A-negative, toxin B-positive Clostridium difficile by
PCR. J Clin Microbiol 36, 2178–2182.
McFarland, L. V. (1995). Epidemiology of infectious and iatrogenic
nosocomial diarrhea in a cohort of general medicine patients. Am
J Infect Control 23, 295–305.
Noren, T., Akerlund, T., Back, E., Sjoberg, L., Persson, I., Alriksson, I.
& Burman, L. G. (2004). Molecular epidemiology of hospital-
associated and community-acquired Clostridium difficile infection in
a Swedish county. J Clin Microbiol 42, 3635–3643.
Riley, T. V., Cooper, M., Bell, B. & Golledge, C. L. (1995).
Community-acquired Clostridium difficile-associated diarrhea. Clin
Infect Dis 20 (Suppl.), 263–265.
Rotimi, V. O., Jama, W. Y., Mokaddas, E. M., Brazier, J. S., Johny, M.
& Duerden, B. I. (2003). Prevalent PCR ribotypes of clinical and
environmental strains of Clostridium difficile isolated from intensive-
therapy unit patients in Kuwait. J Med Microbiol 52, 705–709.
Spencer, R. C. (1998). Clinical impact and associated costs of
Clostridium difficile-associated disease. J Antimicrob Chemother 41
(Suppl.), 5–12.
Stubbs, S. L. J., Brazier, J. S., O’Neil, G. L. & Duerden, B. I. (1999).
PCR targeted to the 16S–23S rRNA gene intergenic spacer region of
Clostridium difficile and construction of a library consisting of 116
different PCR ribotypes. J Clin Microbiol 37, 461–463.
Stubbs, S., Rupnik, M., Gibert, M., Brazier, J., Duerden, B. & Popoff,
M. (2000). Production of actin-specific ADP-ribosyltransferase
(binary toxin) by strains of C. difficile. FEMS Microbiol Lett 186,
307–312.
Terhes, G., Urba´n, E., So´ki, J., Hamid, K. A. & Nagy, E. (2004).
Community-acquired Clostridium difficile caused by binary toxin,
toxin A, toxin B gene-positive isolates in Hungary. J Clin Microbiol
42, 4316–4318.
Urba´n, E., Brazier, J. S., So´ki, J., Nagy, E. & Duerden, B. I. (2001).
PCR ribotyping of clinically important Clostridium difficile strains
from Hungary. J Med Microbiol 50, 1082–1086.
282 Journal of Medical Microbiology 55
G. Terhes and others
